Author: healthadmin

○last month’s versionoil prices bounced around like a lie detector. The joint U.S.-Israeli attack on Iran, which began in February, triggered the biggest one-month price increase in oil history. The price of Brent crude oil rose and fell sharply each time a war broke out. Important points Due to the Iran war, oil price fluctuations have recently intensified around the world. Global financial institutions have consistently identified rising oil prices as the main driver of inflation. Risks of dependence on other countries’ oil have led some countries to expand their use of renewable energy Just as Russian President Vladimir Putin…

Vince Lahey of Carefree, Arizona, embraces chatbots. From big tech products to “shady” products, they offer “someone with whom you can share more secrets than a therapist.” He particularly likes the app for feedback and support, but it can also cause him to get reprimanded and get into fights with his ex-wife. “It made me want to share more,” Lahey said. “I don’t care about their perception of me.” There are many people like Lahey. Demand for mental health care is increasing. The number of self-reported days with poor mental health has increased by 25% since the 1990s, a study…

Millions of people applying for Medicaid in the coming years will need to prove they have worked, attended school or volunteered for at least a month to obtain or maintain health insurance through the government program. But Republican lawmakers in some states don’t think the new rules, part of the GOP’s One Big Beautiful Bill Act, signed by President Donald Trump last July, go far enough. Indiana is at the forefront of this movement, enacting a new law that requires applicants to prove they have worked or participated in similar activities for three consecutive months in order to receive benefits.…

Cancer risk increases with age and is often more aggressive and difficult to treat in older people. However, less than 10% of mouse studies use older animals, and most rely on mice roughly equivalent to humans in their early 20s. This discrepancy is one potential reason why many anticancer drugs that have shown promise in preclinical models continue to fail in human trials.New research from Fox Chase Cancer Center presented at the American Association for Cancer Research annual meeting suggests that melanoma behaves differently with age. The data showed that cancer spread was lowest in young mice, peaked in middle-aged…

The FDA should strengthen the evidence needed to approve drugs under the accelerated pathway and increase transparency around regulatory decisions, according to a report (PDF) from a prominent industry and government watchdog. In the same report, the Institute for Clinical and Economic Review (ICER) also recommends that advisory committees review medicines scheduled for accelerated approval and that pathways more clearly explain the benefits and risks associated with the use of approved medicines within that scope. “The goal of the accelerated approval pathway has always been to give patients access to innovative treatments faster,” Sara Emond, CEO of ICER, said in…

The number of babies born in the United States fell again last year. There will be 3.6 million births in 2025, a 1% decrease from 2024, according to new data from the Centers for Disease Control and Prevention. The birth rate has fallen to 53.1 births per 1,000 women aged 15 to 44, a 23% decrease since 2007. The Trump administration has said it wants to reverse this trend. President Donald Trump has called for a “new baby boom,” and aides are seeking proposals from outside advocates and policy groups on everything from maternity benefits to expanded birth planning. The…

Developmental dysplasia of the hip (DDH) is a polygenetic disease that increases the risk of hip osteoarthritis. A new multi-ethnic study has found that variations in three genes related to collagen and bone formation are associated with DDH. Other downstream genes are also associated with hip osteoarthritis. These findings point to possible mechanisms behind DDH and potential targets for new treatments for hip osteoarthritis. Developmental dysplasia of the hip (DDH) is a disorder of the hip joint that affects posture and movement. Symptoms of DDH can appear as early as a few weeks after birth and can range in severity…

A new study examining the stigma associated with the use of GLP-1 drugs for weight loss found that women who lost weight using GLP-1 drugs were judged more harshly than women who lost weight through diet and exercise, and the negative reaction was primarily driven by the belief that weight loss with drugs was a “shortcut.” The study also found higher levels of prejudice when the women in the sample scenario were depicted as white rather than black. The findings (“Social Perceptions of GLP-1 Weight Loss in Obese Black and White Women”), published April 9 in the American Psychological Association’s…

New research published today stem cell report We demonstrate how a human stem cell-derived intestinal model can be used to identify potential treatments for inflammatory bowel disease (IBD) and highlight glycyrrhizin as a promising candidate for reducing intestinal inflammation and cell death. The burden of IBD is increasing globally, with an estimated 4 million people affected worldwide. The disease is characterized by chronic inflammation of the intestinal wall, causing symptoms such as persistent diarrhea, abdominal pain, and fatigue. Standard treatments include anti-inflammatory drugs and other immune-targeted therapies, but many patients have limited benefit. High-throughput screening (HTS) provides a promising strategy…

After a quiet handover, the legal dispute over Teva and Eli Lilly’s migraine drug has resurfaced, with Teva winning an appeal after reversing an earlier patent win in 2023. The Federal Circuit Court of Appeals on Thursday issued a ruling (PDF) reinstating Teva’s original victory in a 2018 lawsuit alleging patent infringement on its migraine drug Ajovy by Lilly’s rival Emgality. The ruling reinstates a $176.5 judgment that Teva first won in a Boston court in 2022. Teva initially accused Lilly of infringing multiple Ajovi patents related to the use of antibodies to treat migraines by blocking peptides. But despite…